The Conserved Scavenger Receptor Cysteine-Rich Superfamily in Therapy and Diagnosis

被引:180
作者
Gabriela Martinez, Vanesa [1 ]
Moestrup, Soren Kragh [2 ]
Holmskov, Uffe [3 ]
Mollenhauer, Jan [3 ]
Lozano, Francisco [1 ,4 ,5 ]
机构
[1] Inst Invest Biomed August Pi i Sunyer, Ctr Esther Koplowitz, Barcelona 08036, Spain
[2] Aarhus Univ, Dept Med Biochem, Aarhus, Denmark
[3] Univ So Denmark, Inst Mol Med, Odense, Denmark
[4] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain
[5] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Barcelona 7, Spain
关键词
LOW-DENSITY-LIPOPROTEIN; MAC-2; BINDING-PROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSMEMBRANE SERINE-PROTEASE; APOPTOSIS INHIBITORY FACTOR; MEDIATED GENE-TRANSFER; T-CELL-ACTIVATION; PATTERN-RECOGNITION RECEPTORS; ANTI-CD6; MONOCLONAL-ANTIBODY; SYSTEMIC-LUPUS-ERYTHEMATOSUS;
D O I
10.1124/pr.111.004523
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The scavenger receptor cysteine-rich (SRCR) superfamily of soluble or membrane-bound protein receptors is characterized by the presence of one or several repeats of an ancient and highly conserved protein module, the SRCR domain. This superfamily (SRCR-SF) has been in constant and progressive expansion, now up to more than 30 members. The study of these members is attracting growing interest, which parallels that in innate immunity. No unifying function has been described to date for the SRCR domains, this being the result of the limited knowledge still available on the physiology of most members of the SRCR-SF, but also of the sequence versatility of the SRCR domains. Indeed, involvement of SRCR-SF members in quite different functions, such as pathogen recognition, modulation of the immune response, epithelial homeostasis, stem cell biology, and tumor development, have all been described. This has brought to us new information, unveiling the possibility that targeting or supplementing SRCR-SF proteins could result in diagnostic and/or therapeutic benefit for a number of physiologic and pathologic states. Recent research has provided structural and functional insight into these proteins, facilitating the development of means to modulate the activity of SRCR-SF members. Indeed, some of these approaches are already in use, paving the way for a more comprehensive use of SRCR-SF members in the clinic. The present review will illustrate some available evidence on the potential of well known and new members of the SRCR-SF in this regard.
引用
收藏
页码:967 / 1000
页数:34
相关论文
共 439 条
[11]
MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages [J].
Arredouani, MS ;
Palecanda, A ;
Koziel, H ;
Huang, YC ;
Imrich, A ;
Sulahian, TH ;
Ning, YY ;
Yang, ZP ;
Pikkarainen, T ;
Sankala, M ;
Vargas, SO ;
Takeya, M ;
Tryggvason, K ;
Kobzik, L .
JOURNAL OF IMMUNOLOGY, 2005, 175 (09) :6058-6064
[12]
CD6-ligand interactions: a paradigm for SRCR domain function? [J].
Aruffo, A ;
Bowen, MA ;
Patel, DD ;
Haynes, BF ;
Starling, GC ;
Gebe, JA ;
Bajorath, J .
IMMUNOLOGY TODAY, 1997, 18 (10) :498-504
[13]
ASHKENAS J, 1993, J LIPID RES, V34, P983
[14]
A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain [J].
Asuncion, L ;
Fogelgren, B ;
Fong, KSK ;
Fong, SFT ;
Kim, Y ;
Csiszar, K .
MATRIX BIOLOGY, 2001, 20 (07) :487-491
[15]
Cutting edge: Critical role for CD5 in experimental autoimmune encephalomyelitis: Inhibition of engagement reverses disease in mice [J].
Axtell, RC ;
Webb, MS ;
Barnum, SR ;
Raman, C .
JOURNAL OF IMMUNOLOGY, 2004, 173 (05) :2928-2932
[16]
CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity [J].
Azzam, HS ;
Grinberg, A ;
Lui, K ;
Shen, H ;
Shores, EW ;
Love, PE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2301-2311
[17]
Fine tuning of TCR signaling by CD5 [J].
Azzam, HS ;
DeJarnette, JB ;
Huang, K ;
Emmons, R ;
Park, CS ;
Sommers, CL ;
El-Khoury, D ;
Shores, EW ;
Love, PE .
JOURNAL OF IMMUNOLOGY, 2001, 166 (09) :5464-5472
[18]
Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A [J].
Babaev, VR ;
Gleaves, LA ;
Carter, KJ ;
Suzuki, H ;
Kodama, T ;
Fazio, S ;
Linton, MF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2593-2599
[19]
Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis [J].
Baeten, D ;
Moller, HJ ;
Delanghe, J ;
Veys, EM ;
Moestrup, SK ;
De Keyser, F .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1611-1623
[20]
Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression [J].
Bak, S. Peter ;
Walters, Julie Jo ;
Takeya, Motohiro ;
Conejo-Garcia, Jose R. ;
Berwin, Brent L. .
CANCER RESEARCH, 2007, 67 (10) :4783-4789